Resources
Filter by Topic
- Articles
By Chao Li, PhD, Data Scientist at AbbVie, and Mike Munsell, Director of Research at Panalgo
- Press Releases
With more than 1,600 employees across the globe, the new organization is now one of the world’s largest pharma intelligence solutions providers on the market
- Articles
By Meg Richards
Worries and Hopes for Healthcare Delivery in 2024
Industry experts from Norstella – a family of brands that includes, Citeline, the Dedham Group, Evaluate, MMIT, and Panalgo, and whose data and technologies support
Building Effective Real World Evidence Studies to Support New Indications for Established Products
In this article from PharmExec.com, Panalgo’s Executive Director of Solutions Meg Richards, and Dr. Samy Suissa, Founder of the Canadian Network for Observational Drug Effect
Leaning Into RWE: The IRA is Here, So Now’s the Time
Manufacturers are continuing to wrestle with the effects of the Inflation Reduction Act (IRA) on their business plans and revenue streams. Although some of the
Conclusions from Copenhagen: Highlights of ISPOR EU 2023
ISPOR Europe 2023, with the largest number of delegates on record (5,600) was held in wonderful, wonderful Copenhagen (cue the Danny Kaye waltz) last week.
How RWE Improves Evidence Generation Across the Product Life Cycle
Real-world evidence (RWE) is crucial for biopharmaceutical companies and other life sciences organizations to develop the right products for the marketplace. RWE is a powerful
Linking Real-World Data is Like Making a Fine, Blended Wine
In the healthcare and life sciences industries, developments like the explosion of real-world data, new regulatory programs and frameworks, and a focus on AI and
IHD Analytics
Put reliable, rapid analytics in the hands of more people across your organization